Showing results (81-90 of 107) with videos related to
Sort By:
Pageof 11
Cancer Medicine|July 27, 2019
A randomized phase II trial of nab-paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancerZishuo Ian Hu, Johanna C Bendell, Andrea Bullock, et al.Cellular and Molecular Gastroenterology and Hepatology|February 4, 2026
Spatial analysis of IPMNs defines a paradoxical KRT17-positive, low-grade epithelial population harboring malignant featuresJay Li, Georgina Branch, Justin Macchia, et al.Nature Medicine|April 14, 2026
Elraglusib and chemotherapy in metastatic pancreatic ductal adenocarcinoma: a randomized controlled phase 2 trialDevalingam Mahalingam, Rachna T Shroff, Benedito A Carneiro, et al.Iscience|July 24, 2025
Primary and metastatic cellular landscapes in human pancreatic cancerNina G Steele, Veerin R Sirihorachai, Ahmed M Elhossiny, et al.Biorxiv : the Preprint Server for Biology|April 2, 2024
Targeting PIKfyve-driven lipid homeostasis as a metabolic vulnerability in pancreatic cancerCaleb Cheng, Jing Hu, Rahul Mannan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2023
Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced MalignanciesBenedito A Carneiro, Ludimila Cavalcante, Devalingam Mahalingam, et al.Gastrointestinal Endoscopy|October 10, 2024
American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in the diagnosis and management of solid pancreatic masses: summary and recommendations, Jorge D Machicado, Sunil G Sheth, et al.Molecular Cancer Therapeutics|December 17, 2024
Olaparib and Radiotherapy Induce Type I Interferon- and CD8+ T Cell-Dependent Sensitization to Immunotherapy in Pancreatic CancerVictoria M Valvo, Qiang Zhang, Long Jiang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2024
Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With ERBB2/3 Alterations: Results From the Targeted Agent and Profiling Utilization Registry StudyTimothy L Cannon, Michael Rothe, Pam K Mangat, et al.Gut Microbes|July 7, 2026
Isolation of Bacteria and Fungi from Human Pancreatic Tumors and DuodenumDominik Awad, Holly Attebury, Ryan Hong, et al.Pageof 11